Tu, McGlinchey, Wang, Martin, Ching, Floc’h, Kurasawa, Starrett, Lazdun, Wetzel, Nuttall, Ng, Coffman, Smith, Politi, Cooper and Streicher[104] think anti-PD-L1 combination with anti-CD73 promotes T cell response for EGFR-mutated NSCLC. Here, EGFR is linked to non-small cell lung carcinoma.